| Name |
|---|
Spleen_CT1_Non-Cytotoxic CD8+
|
Spleen_CT1_Non-Cytotoxic CD8+
|
|
CD8+ terminally differentiated effector
|
increased effector
|
abnormal cd8-positive, alpha-beta
|
abnormal cd8-positive, alpha-beta
|
decreased cd8-positive, alpha-beta
|
abnormal effector
|
increased cd8-positive, alpha-beta
|
Lymph_Node-cd8-positive, alpha-beta
|
Skin-cd8-positive, alpha-beta
|
Spleen-cd8-positive, alpha-beta
|
increased CD8-positive, alpha-beta
|
decreased CD8-positive, alpha-beta
|
increased effector
|
decreased effector
|
increased CD8-positive, alpha-beta
|
increased central
|
decreased central
|
decreased CD8-positive, alpha-beta
|
increased effector
|
decreased effector
|
increased CD8-positive, alpha-beta
|
CD8+ recently activated effector
|
Respiratory system_CT1_effector
|
Respiratory system_CT1_effector
|
Human - PBMC - L2 - CD8+ Central
|
Human - PBMC - L2 - CD8+ Effector
|
Human - PBMC - L3 - CD8+ Central
|
Human - PBMC - L3 - CD8+ Central
|
Human - PBMC - L3 - CD8+ Central
|
Human - PBMC - L3 - CD8+ Effector
|
Human - PBMC - L3 - CD8+ Effector
|
Human - PBMC - L3 - CD8+ Effector
|
Human - PBMC - L3 - CD8+ Effector
|
Human - PBMC - L3 - CD8+ Effector
|
Human - PBMC - L3 - CD8+ Effector
|
Human - Lung v1 - L2 - CD8+
|
Human - Bone Marrow - L2 - CD8
|
Activated tissue resident
|
Activated effector
|
Tissue resident
|
Effector CD8+
|
Central
|
Effector
|
Revertant
|
|
|
Effector
|
Activated
|
Effector
|
Central
|
Revertant
|
|
Central
|
|
Resident
|
CD8+ tissue-resident
|
Effector
|
Central
|
|
|
Central
|
|
|
Effector
|
Central
|
|
Central
|
Effector
|
Central
|
|
|
negative regulation of
|
regulation of
|
positive regulation of
|
|
|
positive regulation of
|
regulation of
|
impaired
|
decreased
|
abnormal
|
abnormal
|
abnormal
|
increased cd4-positive, alpha-beta
|
abnormal
|
abnormal cd4-positive, alpha-beta
|
decreased
|
abnormal effector
|
increased
|
abnormal
|
abnormal
|
abnormal effector
|
increased effector
|
decreased cd4-positive, alpha-beta
|
abnormal cd4-positive, alpha-beta
|
abnormal
|
Blood-cd4-positive, alpha-beta
|
Blood-
|
Bone_Marrow-
|
Lymph_Node-cd4-positive, alpha-beta
|
Lymph_Node-
|
Salivary_Gland-
|
Skin-cd4-positive, alpha-beta
|
Skin-
|
Spleen-cd4-positive, alpha-beta
|
Spleen-
|
Thymus-
|
Impaired
|
positive regulation of
|
positive regulation of
|
|
|
negative regulation of
|
|
regulation of
|
regulation of
|
increased
|
decreased
|
abnormal
|
abnormal
|
abnormal
|
abnormal
|
decreased
|
abnormal
|
decreased CD4-positive, alpha-beta
|
increased CD4-positive, alpha-beta
|
increased effector
|
abnormal
|
decreased
|
increased
|
increased
|
increased
|
increased
|
increased effector
|
decreased
|
decreased
|
increased
|
increased
|
decreased
|
decreased effector
|
decreased
|
increased central
|
decreased central
|
decreased effector
|
increased
|
decreased
|
decreased effector
|
increased
|
increased effector
|
decreased CD4-positive, alpha-beta
|
decreased
|
increased
|
increased
|
increased
|
increased CD4-positive, alpha-beta
|
decreased
|
decreased
|
decreased
|
Human - PBMC - L2 -
|
Human - PBMC - L3 -
|
Human - PBMC - L3 -
|
Switched
|
Unswitched
|
Switched
|
CD4+ recently activated effector
|
Unswitched
|
Central
|
Switched
|
Central
|
|
|
|
Thoracic thymus_CT1_CD4+ T
|
Respiratory system_CT1_effector
|
Respiratory system_CT1_CD4+ T cell resident
|
Respiratory system_CT1_CD8+ T cell resident
|
Spleen_CT1_Cytotoxic
|
Spleen_CT1_CD4+
|
Blood_CT2_CD4 T cell
|
Blood_CT2_CD4 T cell effector
|
Blood_CT2_CD8 T cell effector
|
Blood_CT2_CD8 T cell effector
|
Liver_CT1_CD8-positive, alpha-beta
|
Liver_CT1_CD8+ Liver-Resident
|
Bone marrow_CT2_CD4 T cell
|
Bone marrow_CT2_CD4 T cell effector
|
Bone marrow_CT2_CD8 T cell
|
Bone marrow_CT2_CD8 T cell effector
|
Bone marrow_CT2_CD8 T cell effector
|
Blood_CT2_CD4 T cell effector
|
Blood_CT2_CD4 T cell
|
Blood_CT2_CD8 T cell effector
|
Blood_CT2_CD8 T cell effector
|
Bone marrow_CT2_CD4 T cell effector
|
Bone marrow_CT2_CD4 T cell
|
Bone marrow_CT2_CD8 T cell effector
|
Bone marrow_CT2_CD8 T cell effector
|
Bone marrow_CT2_CD8 T cell
|
Liver_CT1_CD8+ Liver-Resident
|
Liver_CT1_CD8-positive, alpha-beta
|
Respiratory system_CT1_CD4+ T cell resident
|
Respiratory system_CT1_CD8+ T cell resident
|
Respiratory system_CT1_effector
|
Spleen_CT1_CD4+
|
Spleen_CT1_Cytotoxic
|
Thoracic thymus_CT1_CD4+ T
|
positive regulation of
|
positive regulation of
|
|
|
negative regulation of
|
|
regulation of
|
regulation of
|
|
|
|
|
human long-term
|
cerebral infarction;
|
|
anxiety disorder; blood pressure, arterial;
|
|
dementia;
|
dementia;
|
alzheimer disease; alzheimer's disease;
|
alzheimer disease; alzheimer's disease; aphasia, primary progressive; dementia;
|
|
|
amnesia;
|
|
|
|
epilepsy, temporal lobe;
|
alzheimer disease; alzheimer's disease; disorders of excessive somnolence;
|
alzheimer disease; alzheimer's disease; dementia;
|
anticholinergic challenge-induced
|
alzheimer disease; dementia;
|
|
digeorge syndrome;
|
synaptogenesis and
|
diabetes mellitus type ii; diabetes mellitus, type 2;
|
brain injuries;
|
verbal learning, verbal
|
alzheimer disease; atrophy; dementia;
|
atrophy;
|
learning disorders;
|
asthma; lipids;
|
alzheimer disease; alzheimer's disease; atrophy; dementia;
|
|
irritability hostility impulsivity and
|
alzheimer disease; dementia; hypothyroidism;
|
alzheimer disease; alzheimer's disease; dementia;
|
cardiovascular diseases;
|
insulin; smoking behavior; obesity, localized;
|
cerebral hemorrhage; cerebral hemorrhages;
|
age-associated
|
inflammation;
|
working
|
|
apoplexy;
|
age-associated
|
episodic
|
|
alzheimer disease;
|
chronic progressive chorea;
|
|
|
|
learning or
|
long-term
|
short-term
|
|
Response to antipsychotic treatment in schizophrenia (working
|
|
|
|
|
|
|
|
abnormal object recognition
|
abnormal olfactory -discrimination
|
abnormal learning/
|
abnormal short term object recognition
|
abnormal long term object recognition
|
absent
|
slow extinction of fear
|
abnormal spatial working
|
abnormal long term spatial reference
|
abnormal spatial reference
|
abnormal temporal
|
abnormal short term spatial reference
|
{
|
[
|
|
H3K27me3_CD4
|
H3K27ac_CD4
|
H3K4me1_CD4+ CD25- CD45RO+
|
H3K36me3_CD8
|
H3K9me3_CD4+ CD25- CD45RO+
|
H3K36me3_CD4
|
H3K4me3_CD4
|
H3K4me1_CD8
|
H3K9me3_CD4
|
H3K27me3_CD8
|
H3K36me3_CD4+ CD25- CD45RO+
|
H3K4me3_CD8
|
H3K27ac_CD8
|
H3K27me3_CD4+ CD25- CD45RO+
|
H3K9me3_CD8
|
H3K27ac_CD4+ CD25- CD45RO+
|
H3K4me1_CD4
|
H3K4me3_CD4+ CD25- CD45RO+
|
|
|
Age-Associated
|
|
Short-Term
|
Poor Short-Term
|
|
|
|
|
|
|
Loss Of
|
|
Deficit In Phonologic Short-Term
|
Decreased Proportion Of Class-Switched
|
Increased Proportion Of
|
Pre-Ictal
|
Retrograde
|
|
Decreased Proportion Of
|
|
long-term
|
short-term
|
negative regulation of adaptive immune
|
positive regulation of adaptive immune
|
regulation of adaptive immune
|
abnormal long-term object recognition
|
abnormal learning/
|
abnormal spatial reference
|
abnormal object recognition
|
abnormal temporal
|
abnormal spatial working
|
abnormal long-term spatial reference
|
absent
|
abnormal olfactory discrimination
|
abnormal short-term spatial reference
|
abnormal short-term object recognition
|
fast extinction of fear
|
slow extinction of fear
|
impaired spatial
|
Human - PBMC - L2 - CD4+ Central
|
Human - PBMC - L2 - CD4+ Effector
|
Human - PBMC - L3 - CD4+ Central
|
Human - PBMC - L3 - CD4+ Central
|
Human - PBMC - L3 - CD4+ Central
|
Human - PBMC - L3 - CD4+ Effector
|
Human - PBMC - L3 - CD4+ Effector
|
Human - PBMC - L3 - CD4+ Effector
|
Human - PBMC - L3 - CD4+ Effector
|
Human - PBMC - L3 -
|
Human - Lung v1 - L2 - CD4+
|
Human - Bone Marrow - L2 - CD4
|
Human - Bone Marrow - L2 -
|
Human - Tonsil - L1 -
|
Activated effector
|
|
Tissue resident
|
Effector
|
Activated tissue resident
|
|
Central
|
|
|
|
Atypical
|
Non-switched
|
Switched
|
Double-negative
|
Central
|
Effector
|
Class-switched
|
Switched
|
Effector CD4+
|
|
Central
|
Central
|
Central
|
Effector
|
Effector
|
|
Tissue resident
|
Tissue-like
|
IgA
|
Aged
|
IgM
|
IgG
|
Atypical
|
|
Activated
|
Stem
|
Finally highly effector (TEMRA)
|
Tissue resident
|
|
Intermediate transition
|
Effector
|
|
Precursor
|
Circulating
|
Central
|
Effector
|
Tissue resident
|
Transitional
|
Activated
|
Central
|
Effector
|
Class-switched
|
Non class-switched
|
Class switched
|
Resting
|
IgM
|
CD4+ central
|
CD4+ Terminally Differentiated Effector
|
Non-switched
|
|
Tissue resident
|
Central
|
Tissue resident
|
|
|
|
Central
|
|
Activated
|
Activated
|
IgM
|
Central
|
Effector
|
|
Effector
|
Naive
|
|
|
Effector
|
Naïve or central
|
Tissue resident effector
|
Central
|
|
|
|
|
|
Tissue resident
|
Tissue resident
|
Tissue resident
|
Effector
|
Central
|
|
Activated
|
Resting
|
Effector
|
|
Effector
|
Central
|
|
|
|
Central
|
Effector
|
|
|
Tissue resident
|
Central
|
Tissue resident
|
Central
|
|
Effector
|
Terminal effector
|
|
|
|
|
Central
|
Transitional
|
Tissue resident
|
|
|
|
|
|
Tissue resident
|
|
CD27+
|
|
|
Effector
|
Central
|
Tissue resident
|
Non-recirculating tissue-resident
|
|
Central
|
|
Tissue-resident
|
Tissue resident
|
|
Tissue-resident
|
Central
|
|
|
|
|
|
Resident
|
Tissue resident
|
Tissue resident
|
|
Central
|
Effector
|
|
|
|
Mature
|
Effector
|
Central
|
|
|
Follicular T helper-like
|
IgG
|
|
Natural
|
Central
|
Effector
|
Central
|
Effector
|
|
Stem
|
Central
|
Tissue resident
|
Unswitched and switched
|
Resident
|
|
|
|
T
|
Resident
|
Central
|
|
|
Tissue resident
|
Thoracic thymus_CT1_CD8+ T
|
Thoracic thymus_CT1_CD8+ T
|
|
long-term
|
short-term
|
negative regulation of adaptive immune
|
adaptive immune
|
positive regulation of adaptive immune
|
regulation of adaptive immune
|
|
|
Verbal
|
Verbal
|
|
Short-term
|
Long-term
|
|
Short-term
|
Episodic
|
|
Verbal declarative
|
Response to antipsychotic treatment in schizophrenia (working
|
Logical
|
Logical
|
Logical
|
Logical
|
Logical
|
Logical
|
Logical
|
Logical
|
Verbal
|
Language performance in older adults (adjusted for episodic
|
Age-related cognitive decline (
|
Face
|
Spatial
|
Working
|
AUTOLOGOUS ANTI-BCMA-CAR-4-1BB-CD3ZETA-EXPRESSING MEMORY T-LYMPHOCYTES BB21217 Gene Setinteracting proteins for the AUTOLOGOUS ANTI-BCMA-CAR-4-1BB-CD3ZETA-EXPRESSING MEMORY T-LYMPHOCYTES BB21217 drug from theDGIdb Drug Targets 2026 dataset. |